These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 322152)

  • 21. Naloxone reduces the food intake of normal human volunteers.
    Trenchard E; Silverstone T
    Appetite; 1983 Mar; 4(1):43-50. PubMed ID: 6881960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naloxone does not affect pain relief induced by electrical stimulation in man.
    Freeman TB; Campbell JN; Long DM
    Pain; 1983 Oct; 17(2):189-195. PubMed ID: 6606154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anger management style and emotional reactivity to noxious stimuli among chronic pain patients and healthy controls: the role of endogenous opioids.
    Bruehl S; Burns JW; Chung OY; Quartana P
    Health Psychol; 2008 Mar; 27(2):204-14. PubMed ID: 18377139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceived self-efficacy in coping with cognitive stressors and opioid activation.
    Bandura A; Cioffi D; Taylor CB; Brouillard ME
    J Pers Soc Psychol; 1988 Sep; 55(3):479-88. PubMed ID: 3171918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain.
    Levine JD; Gordon NC; Fields HL
    Nature; 1979 Apr; 278(5706):740-1. PubMed ID: 219371
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical studies of the endogenous opioid system.
    Pickar D; Cohen MR; Naber D; Cohen RM
    Biol Psychiatry; 1982 Nov; 17(11):1243-76. PubMed ID: 6295518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are the endorphins active in clinical pain states? Narcotic antagonism in chronic pain patients.
    Lindblom U; Tegnér R
    Pain; 1979 Aug; 7(1):65-68. PubMed ID: 159425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxone enhances motion sickness: endorphins implicated.
    Allen ME; McKay C; Eaves DM; Hamilton D
    Aviat Space Environ Med; 1986 Jul; 57(7):647-53. PubMed ID: 3741286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-related effects of synthetic human beta-endorphin and naloxone on fed gastrointestinal motility.
    Camilleri M; Malagelada JR; Stanghellini V; Zinsmeister AR; Kao PC; Li CH
    Am J Physiol; 1986 Jul; 251(1 Pt 1):G147-54. PubMed ID: 2942039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
    McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naloxone modulates visual judgments of similarity but not dissimilarity.
    Krummenacher P; Kut E; Folkers G; Brugger P
    Cogn Affect Behav Neurosci; 2013 Sep; 13(3):567-74. PubMed ID: 23494456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of naloxone on normals and chronically anxious patients.
    Hoehn-Saric R; Masek BJ
    Biol Psychiatry; 1981 Nov; 16(11):1041-50. PubMed ID: 7349618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of opiate and adrenergic blockers on the gut motor response to centrally acting stimuli.
    Stanghellini V; Malagelada JR; Zinsmeister AR; Go VL; Kao PC
    Gastroenterology; 1984 Nov; 87(5):1104-13. PubMed ID: 6090258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain relief by electrical stimulation of the periaqueductal and periventricular gray matter. Evidence for a non-opioid mechanism.
    Young RF; Chambi VI
    J Neurosurg; 1987 Mar; 66(3):364-71. PubMed ID: 3493333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
    Preston KL; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1989 Mar; 248(3):929-37. PubMed ID: 2467983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental pain thresholds and plasma beta-endorphin levels during exercise.
    Droste C; Greenlee MW; Schreck M; Roskamm H
    Med Sci Sports Exerc; 1991 Mar; 23(3):334-42. PubMed ID: 2020272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxone antagonizes the local antihyperalgesic effect of fentanyl in burnt skin of healthy humans.
    Robertson LJ; Drummond PD; Hammond GR
    J Pain; 2007 Jun; 8(6):489-93. PubMed ID: 17368995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of naloxone on dental pain threshold following muscle exercise and low frequency transcutaneous nerve stimulation: a comparative study in man.
    Olausson B; Eriksson E; Ellmarker L; Rydenhag B; Shyu BC; Andersson SA
    Acta Physiol Scand; 1986 Feb; 126(2):299-305. PubMed ID: 3486546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects.
    Watson SJ; Berger PA; Akil H; Mills MJ; Barchas JD
    Science; 1978 Jul; 201(4350):73-6. PubMed ID: 351804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.